Companies /Healthcare

Bristol-Myers Squibb Company

NYSE: BMY Drug Manufacturers - General
$66.58
▼ $0.37 (−0.55%) today
Markets closed · 12:05pm ET

BMY Coverage

Page 35
7:27pm ET
Investing

America’s Recession-Proof Companies

With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there are companies that have already proven themselves in the recent recession. They…

Douglas A. McIntyre
10:01am ET
Health and Healthcare

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

The fight against melanoma just got a new weapon after a drug called Yervoy, or ipilimumab, was given FDA approval for late-stage metastatic melanoma.  The approval is a win for Bristol-Myers Squibb Company…

BMY
Jon C. Ogg